Expression and function of PPARγ in rat placental development

Biochemical and Biophysical Research Communications

Volumn 315, Issue 2, 2004, Pages 497-501

  Asami Miyagishi, Reiko ^a,b   Iseki, Sachiko ^a   Usui, Mayumi ^a   Uchida, Koji ^c   Kubo, Harumi ^b   Morita, Ikuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

15 Deoxy 12,14 prostaglandin J2; Labyrinth; Placenta; PPAR ; Trophoblast maturation

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CELL RECEPTOR; CHROMAN DERIVATIVE; DNA; DRUG DERIVATIVE; LIGAND; PROSTAGLANDIN D2; RNA; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EMBRYO DEATH; FEMALE; GENE DELETION; GENE LOCATION; IMMUNOHISTOCHEMISTRY; INNER EAR; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA DEVELOPMENT; PLACENTAL TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; BREEDING; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FETOMATERNAL TRANSFUSION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PLACENTA; PREGNANCY; SPRAGUE DAWLEY RAT; TIME;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CELL DIFFERENTIATION; CHROMANS; DNA; EAR, INNER; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; LIGANDS; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MICROSCOPY, FLUORESCENCE; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; PROSTAGLANDIN D2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; THIAZOLIDINEDIONES; TIME FACTORS; TRANSCRIPTION FACTORS; TROPHOBLASTS;

EID: 0442295112     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.074     Document Type: Article

References (26)

1. Lazennec G., Canaple L., Saugy D., Whali W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 14:2000;1962-1975.
2. Mueller E., Sarraf P., Tontonoz P., Evans R.M., Martin K.J., Zhang M., Fletcher C., Singer S., Spiegelman B.M. Terminal differentiation of human breast cancer through PPARγ Mol. Cell. 1:1998;465-470.
3. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
4. Jones P.S., Savory R., Barrat P., Bell D.R. Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes. Eur. J. Biochem. 233:1995;219-226.
5. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 79:1994;1147-1156.
6. Gearing K.L., Göttlicher M., Teboul M., Widmark E., Gustafsson J.-Å. Interaction of the peroxisome-proliferator-activated receptor and retinoid X Receptor. Proc. Natl. Acad. Sci. USA. 90:1993;1440-1444.
7. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., Evans R.M. PPARγ is required for placental, cardiac, and adipose tissue development. Mol. Cell. 4:1999;585-595.
8. Wendling O., Chambon P., Mark M. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc. Natl. Acad. Sci. USA. 96:1999;547-551.
9. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., Evans R.M. 15-deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83:1995;803-812.
10. Kiewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentitation. Cell. 83:1995;813-819.
11. Nolan J.J., Ludvik B., Beerdsen P., Joyce M., Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N. Engl. J. Med. 331:1994;1188-1193.
12. Fujiwara T., Yoshioka S., Yoshioka T., Ushiyama I., Horikoshi H. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes. 37:1988;1549-1558.
13. Fujiwara T., Wada M., Fukuda K., Fukami M., Yoshioka S., Yoshioka T., Horikoshi H. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice. Metabolism: Clinical and Experimental. 40:1991;1213-1218.
14. Lee M.K., Miles P.D., Khoursheed M., Gao K.M., Moossa A.R., Olefsky J.M. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes. 43:1994;1435-1439.
15. Ershov A.V., Bazan N.G. Photoreceptor phagocytosis selectively activates PPARgamma expression in retinal pigment epithelial cells. J. Neurosci. Res. 60:2000;328-337.
16. Jonsdottir I.H., Schjerling P., Ostrowski K., Asp S., Richter E.A., Pedersen B.K. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J. Physiol. 528:2000;157-163.
17. Shibata T., Kondo M., Osawa T., Shibata N., Kobayashi M., Uchida K. 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J. Biol. Chem. 277:2002;10459-10466.
18. Wu L., de Bruin A., Saavedra H.I., Starovic M., Trimbol A., Yang Y., Opavsk J., Wilson O., Thompson J.C., Ostrowski M.C., Rosol T.J., Woollett L.A., Weinstein M., Cross J.C., Robinson M.L., Leone G. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature. 421:2003;942-947.
19. Jollie W.P. Fine structural changes in placental labyrinth of the rat with increasing gestational age. J. Ultrastruct. Res. 10:1964;27-47.
20. Cross J.C., Hemberger M., Lu Y., Nozaki T., Whiteley K., Masutani M., Adamson S.L. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol. Cell. Endocrinol. 187:2002;207-212.
21. Belknap W.M., Dietschy J.M. Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. J. Clin. Invest. 82:1988;2077-2085.
22. Jurevids H.A., Kidwai F.Z., Morell P. Sources of cholesterol during development of the rat fetus and fetal organs. J. Lipid Res. 38:1997;723-733.
23. Woollett L.A. Origin of cholesterol in the fetal golden Syrian Hamster: contribution of de novo sterol synthesis and maternal-derived lipoprotein cholesterol. J. Lipid Res. 37:1996;1246-1257.
24. Hatzopoulos A.K., Rigotti A., Rosenberg R.D., Krieger M. Temporal and spatial pattern of expression of the HDL receptor SR-BI during murine embryogenesis. J. Lipid Res. 39:1998;495-508.
25. Lee C.-H., Evans R.M. Peroxisome proliferators-activated receptor-γ in macrophage lipid homeostasis. Trends Endocrinol. Metab. 13:2002;331-335.
26. Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M., Moller D.E., Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma2. Biochem. Biophys. Res. Commun. 224:1996;431-437.